HARROW, INC. cotiza a 29.11 USD y tiene una capitalización bursátil de $1.1B. En los últimos 12 meses ha facturado $276M con un margen de flujo de caja libre del 15.8%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.46 | $-0.74 | $0.27 |
| Estimado | $0.32 | $-0.24 | $-0.33 | $0.48 |
| Sorpresa | — | -91.7% | -124.2% | -43.7% |
| Métrica | HROW | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 75.0% | 57.0% | +18.0% |
| Operating Margin | 11.2% | -38.6% | +49.8% |
| Net Margin | -1.9% | -33.6% | +31.7% |
| FCF Margin | 15.8% | -13.9% | +29.6% |
| ROE | -9.8% | -40.4% | +30.6% |
| ROA | -1.3% | -32.0% | +30.7% |
| Current Ratio | 2.20 | 2.84 | -0.64 |
| Debt / Equity | 4.77 | 0.28 | +4.49 |